Agomelatine CAS 6836-19-7: Your Key to Neurological Advancement
Unlock potential in depression treatment with our high-purity melatoninergic agonist and 5-HT2C antagonist.
Get a Quote & SampleProduct Core Value
Agomelatine
Agomelatine is a vital pharmaceutical intermediate acting as a melatoninergic agonist and a selective antagonist of 5-HT2C receptors. Its demonstrated activity in animal models of depression makes it a crucial compound for research and development in neurological therapies.
- Discover the benefits of high purity agomelatine powder for your synthesis needs.
- Explore the potential of melatoninergic agonist 5-HT2C antagonist for CNS drug research.
- Benefit from a GMP certified agomelatine manufacturer, ensuring quality and compliance.
- Secure a reliable source for customizable agomelatine chemical for your specific project requirements.
Key Advantages
Uncompromising Purity
Our Agomelatine chemical offers purity exceeding 99%, a critical factor for reliable pharmaceutical synthesis and research outcomes.
Dual Mechanism of Action
Leverage the unique properties of this melatoninergic agonist and 5-HT2C antagonist to advance your research into depression and related neurological conditions.
Certified Quality Assurance
Rely on a manufacturer with ISO9001, GMP, FDA, and CEP certifications, assuring you of stringent quality control throughout the production process.
Key Applications
Pharmaceutical Synthesis
Utilize Agomelatine CAS 6836-19-7 as a key building block in the synthesis of novel therapeutic agents.
CNS Drug Research
Investigate the effects of this melatoninergic agonist and 5-HT2C antagonist in models of depression and other central nervous system disorders.
Melatonergic Systems Study
Advance understanding of the melatoninergic system and its role in circadian rhythms and mood regulation.
5-HT2C Receptor Modulation
Explore the therapeutic potential of targeting 5-HT2C receptors for psychiatric conditions.